Relenza News
Most Popular Relenza Story
Flu shots, Relenza to benefit from Tamiflu trouble
In the medical journal equivalent of a newspaper Extra! edition, the Journal of the American Medical Association went to press early with several stories on this year's flu resistance to Roche's... Read more...
Latest Headlines
- September 8, 2009
- September 4, 2009
- August 10, 2009
- August 4, 2009
- July 23, 2009
- May 4, 2009
- May 4, 2009
- April 27, 2009
- March 3, 2009
- February 6, 2009
- December 22, 2008
- September 4, 2008
- August 7, 2008
- June 5, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
